Subsidiary obtaining Sharp Life Science shares

Subject: Subsidiary Sharp FMSG Healthcare and Medical Company KY obtaining Sharp Life Science Corporation shares

Date of events:2017/04/14

Contents:

1.Name and nature of the subject matter (if preferred shares, the terms and conditions of issuance shall also be indicated, e.g.dividend yield):

Sharp Life Science Corporation shares

2.Date of occurrence of the event: 2017/03/01~2017/04/14

3.Volume, unit price, and total monetary amount of the transaction:

27,743 shares at JPY50,000 each;Total amount equals JPY1,387,144,338

4.The manner in which the current transaction was decided, the reference basis for the decision on price, and the decision-making department:

Board of Directors

5.Current cumulative volume, amount, and shareholding percentage of holdings of the security being traded (including the current trade) and status of any restriction of rights (e.g.pledges):

27,743 shares；JPY1,387,144,338；100%；None

6.Current ratio of long or short term securities investment (including the current trade) to the total assets and shareholder's equity as shown in the most recent financial statement and the operating capital as shown in the most recent financial statement:

Ratio to total assets:0.0133%,to shareholder's equity:0.0359%

Operating Capital:NTD-40,666,643,000

7.Concrete purpose or use of the acquisition or disposal:

Long Term Investment

8.Any other matters that need to be specified:

Sharp Healthcare and Medical Company KY change its name to Sharp FMSG Healthcare and Medical Company KY